96 related articles for article (PubMed ID: 23532250)
1. A structure-based design of new C2- and C13-substituted taxanes: tubulin binding affinities and extended quantitative structure-activity relationships using comparative binding energy (COMBINE) analysis.
Coderch C; Tang Y; Klett J; Zhang SE; Ma YT; Shaorong W; Matesanz R; Pera B; Canales A; Jiménez-Barbero J; Morreale A; Díaz JF; Fang WS; Gago F
Org Biomol Chem; 2013 May; 11(18):3046-56. PubMed ID: 23532250
[TBL] [Abstract][Full Text] [Related]
2. Comparative binding energy (COMBINE) analysis supports a proposal for the binding mode of epothilones to β-tubulin.
Coderch C; Klett J; Morreale A; Fernando Díaz J; Gago F
ChemMedChem; 2012 May; 7(5):836-43. PubMed ID: 22431398
[TBL] [Abstract][Full Text] [Related]
3. Optimization of taxane binding to microtubules: binding affinity dissection and incremental construction of a high-affinity analog of paclitaxel.
Matesanz R; Barasoain I; Yang CG; Wang L; Li X; de Inés C; Coderch C; Gago F; Barbero JJ; Andreu JM; Fang WS; Díaz JF
Chem Biol; 2008 Jun; 15(6):573-85. PubMed ID: 18559268
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of C2-C3'N-linked macrocyclic taxoids. Novel docetaxel analogues with high tubulin activity.
Querolle O; Dubois J; Thoret S; Roussi F; Guéritte F; Guénard D
J Med Chem; 2004 Nov; 47(24):5937-44. PubMed ID: 15537348
[TBL] [Abstract][Full Text] [Related]
5. Overcoming tumor drug resistance with C2-modified 10-deacetyl-7-propionyl cephalomannines: a QSAR study.
Hansch C; Verma RP
Mol Pharm; 2009; 6(3):849-60. PubMed ID: 19334723
[TBL] [Abstract][Full Text] [Related]
6. Taxanes with high potency inducing tubulin assembly overcome tumoural cell resistances.
Matesanz R; Trigili C; Rodríguez-Salarichs J; Zanardi I; Pera B; Nogales A; Fang WS; Jímenez-Barbero J; Canales A; Barasoain I; Ojima I; Díaz JF
Bioorg Med Chem; 2014 Sep; 22(18):5078-90. PubMed ID: 25047938
[TBL] [Abstract][Full Text] [Related]
7. Applying linear interaction energy method for binding affinity calculations of podophyllotoxin analogues with tubulin using continuum solvent model and prediction of cytotoxic activity.
Alam MA; Naik PK
J Mol Graph Model; 2009; 27(8):930-43. PubMed ID: 19286405
[TBL] [Abstract][Full Text] [Related]
8. Binding orientations, QSAR, and molecular design of thiophene derivative inhibitors.
Liao SY; Chen TJ; Miao TF; Qian L; Zheng KC
Chem Biol Drug Des; 2009 Sep; 74(3):289-96. PubMed ID: 19703031
[TBL] [Abstract][Full Text] [Related]
9. Novel C2-C3' N-peptide linked macrocyclic taxoids. Part 1: Synthesis and biological activities of docetaxel analogues with a peptide side chain at C3'.
Larroque AL; Dubois J; Thoret S; Aubert G; Guénard D; Guéritte F
Bioorg Med Chem Lett; 2005 Nov; 15(21):4722-6. PubMed ID: 16165352
[TBL] [Abstract][Full Text] [Related]
10. 3D QSAR studies for the beta-tubulin binding site of microtubule-stabilizing anticancer agents (MSAAs): a pseudoreceptor model for taxanes based on the experimental structure of tubulin.
Maccari L; Manetti F; Corelli F; Botta M
Farmaco; 2003 Sep; 58(9):659-68. PubMed ID: 13679158
[TBL] [Abstract][Full Text] [Related]
11. Insights into the interaction of discodermolide and docetaxel with tubulin. Mapping the binding sites of microtubule-stabilizing agents by using an integrated NMR and computational approach.
Canales A; Rodríguez-Salarichs J; Trigili C; Nieto L; Coderch C; Andreu JM; Paterson I; Jiménez-Barbero J; Díaz JF
ACS Chem Biol; 2011 Aug; 6(8):789-99. PubMed ID: 21539341
[TBL] [Abstract][Full Text] [Related]
12. Structural insight into the stabilization of microtubules by taxanes.
Prota AE; Lucena-Agell D; Ma Y; Estevez-Gallego J; Li S; Bargsten K; Josa-Prado F; Altmann KH; Gaillard N; Kamimura S; Mühlethaler T; Gago F; Oliva MA; Steinmetz MO; Fang WS; Díaz JF
Elife; 2023 Mar; 12():. PubMed ID: 36876916
[TBL] [Abstract][Full Text] [Related]
13. Cyclostreptin (FR182877), an antitumor tubulin-polymerizing agent deficient in enhancing tubulin assembly despite its high affinity for the taxoid site.
Edler MC; Buey RM; Gussio R; Marcus AI; Vanderwal CD; Sorensen EJ; Díaz JF; Giannakakou P; Hamel E
Biochemistry; 2005 Aug; 44(34):11525-38. PubMed ID: 16114889
[TBL] [Abstract][Full Text] [Related]
14. Understanding tubulin/microtubule-taxane interactions: a quantitative structure-activity relationship study.
Hansch C; Verma RP
Mol Pharm; 2008; 5(1):151-61. PubMed ID: 18171015
[TBL] [Abstract][Full Text] [Related]
15. Elucidating the mechanism of action of the clinically approved taxanes: a comprehensive comparison of local and allosteric effects.
Churchill CD; Klobukowski M; Tuszynski JA
Chem Biol Drug Des; 2015 Nov; 86(5):1253-66. PubMed ID: 26032329
[TBL] [Abstract][Full Text] [Related]
16. Mapping the binding site of a large set of quinazoline type EGF-R inhibitors using molecular field analyses and molecular docking studies.
Hou T; Zhu L; Chen L; Xu X
J Chem Inf Comput Sci; 2003; 43(1):273-87. PubMed ID: 12546563
[TBL] [Abstract][Full Text] [Related]
17. The T-Taxol conformation.
Alcaraz AA; Mehta AK; Johnson SA; Snyder JP
J Med Chem; 2006 Apr; 49(8):2478-88. PubMed ID: 16610791
[TBL] [Abstract][Full Text] [Related]
18. Experimental and computational study of the interaction of novel colchicinoids with a recombinant human αI/βI-tubulin heterodimer.
Mane JY; Semenchenko V; Perez-Pineiro R; Winter P; Wishart D; Tuszynski JA
Chem Biol Drug Des; 2013 Jul; 82(1):60-70. PubMed ID: 23480279
[TBL] [Abstract][Full Text] [Related]
19. CoMFA, HQSAR and molecular docking studies of butitaxel analogues with beta-tubulin.
Cunningham SL; Cunningham AR; Day BW
J Mol Model; 2005 Feb; 11(1):48-54. PubMed ID: 15616834
[TBL] [Abstract][Full Text] [Related]
20. Binding conformations and QSAR of CA-4 analogs as tubulin inhibitors.
Liao SY; Chen JC; Miao TF; Shen Y; Zheng KC
J Enzyme Inhib Med Chem; 2010 Jun; 25(3):421-9. PubMed ID: 19874191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
